Global Drug formulations Market Research Report
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
Antiseptics and corticosteroids Antiseptics and corticosteroids and its peer markets - E-Clinical Trial Solutions, |
Upcoming |
|
Sulfonamides and corticosteroids Sulfonamides and corticosteroids and its peer markets - Chromatography, |
Upcoming |
|
Imidazole derivatives and corticosteroids Imidazole derivatives and corticosteroids and its peer markets - Next Generation Sequencing (NGS), |
Upcoming |
|
Gynecological Ergot alkaloids Gynecological Ergot alkaloids and its peer markets - Digital Pathology, |
Upcoming |
|
Gynecological Ergot alkaloids and oxytocin incl. analogues, in combination Gynecological Ergot alkaloids and oxytocin incl. analogues, in combination and its peer markets - Chromatography Instruments, |
Upcoming |
|
Gynecological Prostaglandins Gynecological Prostaglandins and its peer markets - Healthcare IT outsourcing, |
Upcoming |
|
Intravaginal contraceptives Intravaginal contraceptives and its peer markets - Immunoassay, |
Upcoming |
|
Sympathomimetics, labour repressants Sympathomimetics, labour repressants and its peer markets - Other gynecologicals, |
Upcoming |
|
Prolactine inhibitors Prolactine inhibitors and its peer markets - Clinical Trial Management Systems (CTMS), |
Upcoming |
|
Antiinflammatory products for vaginal administration Antiinflammatory products for vaginal administration and its peer markets - Healthcare IT outsourcing, |
Upcoming |
|
3-oxoandrosten (4) derivatives 3-oxoandrosten (4) derivatives and its peer markets - Next Generation Sequencing (NGS), |
Upcoming |
|
5-androstanon (3) derivatives 5-androstanon (3) derivatives and its peer markets - Immunoassay, |
Upcoming |
|
Natural and semisynthetic estrogens, plain Natural and semisynthetic estrogens, plain and its peer markets - Next Generation Sequencing (NGS), |
Upcoming |
|
Synthetic estrogens, plain Synthetic estrogens, plain and its peer markets - Chromatography Instruments, |
Upcoming |
|
Estrogens, combinations with other drugs Estrogens, combinations with other drugs and its peer markets - Proteomics, |
Upcoming |
|
Pregnen (4) derivatives Pregnen (4) derivatives and its peer markets - Healthcare IT outsourcing, |
Upcoming |
|
Pregnadien derivatives Pregnadien derivatives and its peer markets - Chromatography Instruments, |
Upcoming |
|
Estren derivatives Estren derivatives and its peer markets - Chromatography Instruments, |
Upcoming |
|
Androgens and estrogens Androgens and estrogens and its peer markets - Androgens and female sex hormones in combination with other drugs, |
Upcoming |
|
Androgen, progestogen and estrogen in combination Androgen, progestogen and estrogen in combination and its peer markets - Next Generation Sequencing (NGS), |
Upcoming |
Drug formulations





